Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
The FEBS Journal|July 8, 2024
The role of interleukin-6 family cytokines in cancer cachexiaSamet Agca, Serkan KirCurrent Opinion in Supportive and Palliative Care|May 27, 2024
EDA2R-NIK signaling in cancer cachexiaSamet Agca, Serkan KirTrends in Molecular Medicine|November 1, 2025
Transcriptional landscape of skeletal muscle in cancer patientsSamet Agca, Serkan KirJournal of Cachexia, Sarcopenia and Muscle|April 4, 2022
Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexiaBahar Zehra Camurdanoglu Weber, Samet Agca, Aylin Domaniku, et al.Journal of Cachexia, Sarcopenia and Muscle|July 13, 2024
Tumour-induced alterations in single-nucleus transcriptome of atrophying muscles indicate enhanced protein degradation and reduced oxidative metabolismSamet Agca, Aylin Domaniku-Waraich, Sevval Nur Bilgic, et al.The FEBS Journal|May 23, 2026
Adipocyte-specific NIK depletion enhances energy metabolism and glucose tolerance in miceAtakan Ozcan, Caroline Uslucan, Aleyna Kizilyer, et al.Cell Reports. Medicine|April 3, 2024
Oncostatin M signaling drives cancer-associated skeletal muscle wastingAylin Domaniku-Waraich, Samet Agca, Batu Toledo, et al.Nature|May 10, 2023
EDA2R-NIK signalling promotes muscle atrophy linked to cancer cachexiaSevval Nur Bilgic, Aylin Domaniku, Batu Toledo, et al.Trends in Molecular Medicine|March 5, 2024
Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiologySevgi Döndü Özen, Serkan KirTrends in Cancer|May 2, 2017
CACHEXIA & BROWN FAT: A BURNING ISSUE IN CANCERSerkan Kir, Bruce M SpiegelmanPageof 3